
When a micro-cap corporate shell reboots its identity, the real story rarely lives in the press release. For ADI GLOBAL DISTRIBUTION INC. (ADIG), a quick look at the SEC filing ledger reveals a rapid sequence of structural maneuvers that warrant a careful read of the underlying documents rather than reliance on executive optimism.

The paper trail accelerated in early August 2026 with a heavily loaded Form 8-K. The disclosure hit multiple critical regulatory triggers, including Item 1.01 for material agreements, Item 5.01 for a change of control, and Item 3.02 covering unregistered sales of equity securities. When a change of control pairs directly with unregistered share issuances, the fundamental cap table mechanics are immediately rewritten, shifting governance and potential share overhang before public markets fully adjust.
Shortly after following up with an Item 2.02 earnings announcement and a quarterly report on Form 10-Q, the EDGAR feed showed another notable pattern: three consecutive Form 144 notices filed on August 19, August 20, and August 21, preceded by an insider Form 4 transaction. Form 144 filings represent intended sales of restricted or control securities under Rule 144, signaling that shareholders holding restricted blocks are preparing for potential liquidity events in the open market.
For retail investors tracking micro-cap transitions, assessing the structural mechanics behind equity issuances is crucial. Evaluating this activity through our dilution-risk framework highlights how private placements and restricted share releases can alter the supply dynamics of a thinly traded float over time.
ADIG is clearly in the middle of a corporate transformation, but transformation brings structural supply to the market. Knowing what you own means looking past headline changes and watching how newly issued shares and insider filing notices translate into real market supply.
Each week: the micro and small-caps now showing dilution or paid-promotion signals, with the SEC filing behind every flag. No recommendations, no price targets.